NASDAQ:QTRX Quanterix Q3 2026 Earnings Date & Estimates $3.28 0.00 (0.00%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$3.28 0.00 (0.00%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Quanterix is scheduled to report Q3 2026 earnings on Monday, November 9, 2026. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 9, 2026Conference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Quanterix in Q3 2026Quanterix is expected to post earnings of -$0.4295 per share on revenue of $34.72 million. In the same quarter a year earlier Quanterix reported -$0.36 per share on revenue of $40.23 million. Quanterix last reported on August 10, 2026, posting -$1.04 per share and missing the -$0.4103 consensus estimate. Quanterix has beaten the consensus EPS estimate in 2 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.4295Expected Revenue$34.72 millionPrior-Year EPS-$0.36Prior-Year Revenue$40.23 millionExpected Revenue Growth-13.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$1.04 (Missed by -$0.6297)Last Quarter Revenue$32.91 millionEPS Beat Rate2 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Quanterix Q3 2026 Earnings FAQ When does Quanterix report Q3 2026 earnings? Quanterix (NASDAQ:QTRX) is scheduled to report Q3 2026 earnings on Monday, November 9, 2026. What time is Quanterix's Q3 2026 earnings call? Quanterix's Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Quanterix? Analysts expect Quanterix to post earnings of -$0.4295 per share for Q3 2026. How much revenue is Quanterix expected to report? The consensus revenue estimate for Quanterix is $34.72 million for Q3 2026. Quanterix Earnings HeadlinesALZpath and Quanterix Expand Strategic Licensing Agreement to Advance Next Generation Alzheimer's Disease Biomarker ResearchOctober 8, 2026 | marketscreener.comMQuanterix and Innovita Expand IVD Access in China with National Medical Products Administration ApprovalsOctober 7, 2026 | finance.yahoo.comUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider sources say Elon Musk is developing a breakthrough technology he describes as '10x bigger than the largest product in history.' Nvidia's CEO has called it 'the next biggest opportunity after AI,' with potential lifetime sales reaching $20 trillion. A launch date of July 22nd is on the radar for early investors positioning ahead of the announcement.October 12 at 1:00 AM | StocksToTrade (Ad)Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026September 25, 2026 | markets.ft.comQuanterix Corporation Launches PhenoCode 2.0 Molecular Barcoding Kit, Confirms TIME And High-Plex ADC Panels For Fourth Quarter Shipment, And Opens Custom ADC Panel DevelopmentSeptember 25, 2026 | marketscreener.comMQuanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 16, 2026 | businesswire.comSee More Quanterix Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Quanterix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quanterix and other key companies, straight to your email. Email Address About QuanterixQuanterix (NASDAQ:QTRX) (NASDAQ:QTRX) is a life sciences company that develops technologies for detecting and measuring very low concentrations of biomarkers in blood and other biological samples. Its platform is designed to support research and clinical development in areas including neurology, oncology, immunology, infectious diseases and cardiovascular disease. The company’s core technology, Simoa (Single Molecule Array), uses digital immunoassay methods to detect proteins and other biomarkers at levels below the practical range of many conventional laboratory tests. Quanterix offers laboratory instruments such as the HD-X, SR-X and SP-X systems, along with assay kits, consumables, software and related laboratory services. Its products are used by pharmaceutical and biotechnology companies, academic and government researchers, diagnostic developers and clinical laboratories. Founded in 2007 and headquartered in Billerica, Massachusetts, Quanterix serves customers through direct and commercial channels in the United States and internationally. The company has also expanded its offerings through partnerships and acquisitions, including the addition of technologies intended to broaden its biomarker analysis capabilities. Masoud Toloue has served as Quanterix’s president and chief executive officer since January 2024.View Quanterix ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
